Moderna is Urged to Work Through African Partnership to Set up mRNA Facility 07/10/2021 Kerry Cullinan Moderna should work through the Partnership for African Vaccine Manufacturing (PAVM) if it wants to invest in vaccine production on the continent, according to the head of the Africa Centers for Disease Control (CDC). The company announced on Thursday that it plans to invest $500-million in a “state-of-the-art mRNA facility” in Africa that can produce […] Continue reading -> Jamaica, Nicaragua and Haiti Fail to Reach 10% COVID-19 Vaccination Target 07/10/2021 Raisa Santos Jamaica, Nicaragua, and Haiti were the only three member countries of the Pan American Health Organization (PAHO) that failed to meet the World Health Organization (WHO) target of vaccinating 10% of their populations against COVID-19 by the end of September. Around 37% of people in Latin America and the Caribbean have been fully vaccinated against […] Continue reading -> WHO Approves First Ever Malaria Vaccine 06/10/2021 Kerry Cullinan The World Health Organization (WHO) has given the go-ahead for children to get the first-ever malaria vaccine in areas where there is a high to moderate risk of infection. The vaccine, known as RTS,S, is the first to have been approved against a parasitic disease. It has been tested on 800,000 children in Ghana, Kenya […] Continue reading -> African Countries Finally Give Continental Medicines Agency the Go-ahead 06/10/2021 Kerry Cullinan Africans are a step closer to speedier access to newer, safer medicines following this week’s ratification of the African Medicines Agency (AMA) treaty by 15 African Union (AU) member countries. Although the AU adopted the treaty to set up the AMA back in February 2019, 15 African countries had to formally notify the AU Commission […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> A New Pandemic Treaty, Revised International Health Regulations, or Both? What is the Actual Roadmap? 02/10/2021 Gian Luca Burci The World Health Assembly is set to make a fateful decision in November over whether to negotiate a new international ‘Pandemic Treaty’ to improve future pandemic preparedness and response. However, major players like the United States, backed by some civil society groups, have suggested that revisions of the existing International Health Regulations (IHR) would be […] Continue reading -> Tuberculosis is Here to Stay if We Don’t Mobilise Resources for Diagnoses and Double Fundings, New Data Shows 01/10/2021 Aishwarya Tendolkar The COVID-19 pandemic and the consequent diversion of resources toward battling SARS-CoV2 has also set back global efforts to eliminate the world’s second most deadly infectious killer: Tuberculosis, by 2030. Only a doubling of investments next year can pave the way to attainment of the 2030 United Nations Sustainable Development Goals to eliminate the disease, […] Continue reading -> New Social Contract and One Health Approach Critical to Resilient Recovery from COVID Pandemic 01/10/2021 Madeleine Hoecklin A new social contract between European governments and their citizens is needed to lay the foundation for a resilient and sustainable recovery from the COVID-19 pandemic, with health at the center, said panelists at the closing session of the European Health Forum Gastein (EHFG) on Friday. A focus on ensuring social protection and equitable access […] Continue reading -> MSF Urges Sanofi to Share Technology and Know-how with WHO’s mRNA Vaccine Hub 01/10/2021 Editorial team Following news that Sanofi, a French pharma company, will abandon its promising mRNA COVID-19 vaccine candidate, Médecins Sans Frontières (MSF) called for the corporation to transfer the vaccine technology and know-how to the WHO-led COVID-19 mRNA vaccine technology transfer hub in South Africa. Despite the existence of two approved mRNA vaccines and 13 candidates in advanced stages […] Continue reading -> Childhood Vaccinations Remain High Despite COVID Pandemic 01/10/2021 Editorial team New statistics from Gavi, the Vaccine Alliance show that routine immunisation programmes have been hit hard by the COVID-19 pandemic. However, the latest data shows that there is extraordinary resilience in immunisation systems, with governments’ efforts to keep childhood vaccinations going despite the impact of the pandemic paying dividends. In the face of the pandemic, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Jamaica, Nicaragua and Haiti Fail to Reach 10% COVID-19 Vaccination Target 07/10/2021 Raisa Santos Jamaica, Nicaragua, and Haiti were the only three member countries of the Pan American Health Organization (PAHO) that failed to meet the World Health Organization (WHO) target of vaccinating 10% of their populations against COVID-19 by the end of September. Around 37% of people in Latin America and the Caribbean have been fully vaccinated against […] Continue reading -> WHO Approves First Ever Malaria Vaccine 06/10/2021 Kerry Cullinan The World Health Organization (WHO) has given the go-ahead for children to get the first-ever malaria vaccine in areas where there is a high to moderate risk of infection. The vaccine, known as RTS,S, is the first to have been approved against a parasitic disease. It has been tested on 800,000 children in Ghana, Kenya […] Continue reading -> African Countries Finally Give Continental Medicines Agency the Go-ahead 06/10/2021 Kerry Cullinan Africans are a step closer to speedier access to newer, safer medicines following this week’s ratification of the African Medicines Agency (AMA) treaty by 15 African Union (AU) member countries. Although the AU adopted the treaty to set up the AMA back in February 2019, 15 African countries had to formally notify the AU Commission […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> A New Pandemic Treaty, Revised International Health Regulations, or Both? What is the Actual Roadmap? 02/10/2021 Gian Luca Burci The World Health Assembly is set to make a fateful decision in November over whether to negotiate a new international ‘Pandemic Treaty’ to improve future pandemic preparedness and response. However, major players like the United States, backed by some civil society groups, have suggested that revisions of the existing International Health Regulations (IHR) would be […] Continue reading -> Tuberculosis is Here to Stay if We Don’t Mobilise Resources for Diagnoses and Double Fundings, New Data Shows 01/10/2021 Aishwarya Tendolkar The COVID-19 pandemic and the consequent diversion of resources toward battling SARS-CoV2 has also set back global efforts to eliminate the world’s second most deadly infectious killer: Tuberculosis, by 2030. Only a doubling of investments next year can pave the way to attainment of the 2030 United Nations Sustainable Development Goals to eliminate the disease, […] Continue reading -> New Social Contract and One Health Approach Critical to Resilient Recovery from COVID Pandemic 01/10/2021 Madeleine Hoecklin A new social contract between European governments and their citizens is needed to lay the foundation for a resilient and sustainable recovery from the COVID-19 pandemic, with health at the center, said panelists at the closing session of the European Health Forum Gastein (EHFG) on Friday. A focus on ensuring social protection and equitable access […] Continue reading -> MSF Urges Sanofi to Share Technology and Know-how with WHO’s mRNA Vaccine Hub 01/10/2021 Editorial team Following news that Sanofi, a French pharma company, will abandon its promising mRNA COVID-19 vaccine candidate, Médecins Sans Frontières (MSF) called for the corporation to transfer the vaccine technology and know-how to the WHO-led COVID-19 mRNA vaccine technology transfer hub in South Africa. Despite the existence of two approved mRNA vaccines and 13 candidates in advanced stages […] Continue reading -> Childhood Vaccinations Remain High Despite COVID Pandemic 01/10/2021 Editorial team New statistics from Gavi, the Vaccine Alliance show that routine immunisation programmes have been hit hard by the COVID-19 pandemic. However, the latest data shows that there is extraordinary resilience in immunisation systems, with governments’ efforts to keep childhood vaccinations going despite the impact of the pandemic paying dividends. In the face of the pandemic, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Approves First Ever Malaria Vaccine 06/10/2021 Kerry Cullinan The World Health Organization (WHO) has given the go-ahead for children to get the first-ever malaria vaccine in areas where there is a high to moderate risk of infection. The vaccine, known as RTS,S, is the first to have been approved against a parasitic disease. It has been tested on 800,000 children in Ghana, Kenya […] Continue reading -> African Countries Finally Give Continental Medicines Agency the Go-ahead 06/10/2021 Kerry Cullinan Africans are a step closer to speedier access to newer, safer medicines following this week’s ratification of the African Medicines Agency (AMA) treaty by 15 African Union (AU) member countries. Although the AU adopted the treaty to set up the AMA back in February 2019, 15 African countries had to formally notify the AU Commission […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> A New Pandemic Treaty, Revised International Health Regulations, or Both? What is the Actual Roadmap? 02/10/2021 Gian Luca Burci The World Health Assembly is set to make a fateful decision in November over whether to negotiate a new international ‘Pandemic Treaty’ to improve future pandemic preparedness and response. However, major players like the United States, backed by some civil society groups, have suggested that revisions of the existing International Health Regulations (IHR) would be […] Continue reading -> Tuberculosis is Here to Stay if We Don’t Mobilise Resources for Diagnoses and Double Fundings, New Data Shows 01/10/2021 Aishwarya Tendolkar The COVID-19 pandemic and the consequent diversion of resources toward battling SARS-CoV2 has also set back global efforts to eliminate the world’s second most deadly infectious killer: Tuberculosis, by 2030. Only a doubling of investments next year can pave the way to attainment of the 2030 United Nations Sustainable Development Goals to eliminate the disease, […] Continue reading -> New Social Contract and One Health Approach Critical to Resilient Recovery from COVID Pandemic 01/10/2021 Madeleine Hoecklin A new social contract between European governments and their citizens is needed to lay the foundation for a resilient and sustainable recovery from the COVID-19 pandemic, with health at the center, said panelists at the closing session of the European Health Forum Gastein (EHFG) on Friday. A focus on ensuring social protection and equitable access […] Continue reading -> MSF Urges Sanofi to Share Technology and Know-how with WHO’s mRNA Vaccine Hub 01/10/2021 Editorial team Following news that Sanofi, a French pharma company, will abandon its promising mRNA COVID-19 vaccine candidate, Médecins Sans Frontières (MSF) called for the corporation to transfer the vaccine technology and know-how to the WHO-led COVID-19 mRNA vaccine technology transfer hub in South Africa. Despite the existence of two approved mRNA vaccines and 13 candidates in advanced stages […] Continue reading -> Childhood Vaccinations Remain High Despite COVID Pandemic 01/10/2021 Editorial team New statistics from Gavi, the Vaccine Alliance show that routine immunisation programmes have been hit hard by the COVID-19 pandemic. However, the latest data shows that there is extraordinary resilience in immunisation systems, with governments’ efforts to keep childhood vaccinations going despite the impact of the pandemic paying dividends. In the face of the pandemic, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
African Countries Finally Give Continental Medicines Agency the Go-ahead 06/10/2021 Kerry Cullinan Africans are a step closer to speedier access to newer, safer medicines following this week’s ratification of the African Medicines Agency (AMA) treaty by 15 African Union (AU) member countries. Although the AU adopted the treaty to set up the AMA back in February 2019, 15 African countries had to formally notify the AU Commission […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> A New Pandemic Treaty, Revised International Health Regulations, or Both? What is the Actual Roadmap? 02/10/2021 Gian Luca Burci The World Health Assembly is set to make a fateful decision in November over whether to negotiate a new international ‘Pandemic Treaty’ to improve future pandemic preparedness and response. However, major players like the United States, backed by some civil society groups, have suggested that revisions of the existing International Health Regulations (IHR) would be […] Continue reading -> Tuberculosis is Here to Stay if We Don’t Mobilise Resources for Diagnoses and Double Fundings, New Data Shows 01/10/2021 Aishwarya Tendolkar The COVID-19 pandemic and the consequent diversion of resources toward battling SARS-CoV2 has also set back global efforts to eliminate the world’s second most deadly infectious killer: Tuberculosis, by 2030. Only a doubling of investments next year can pave the way to attainment of the 2030 United Nations Sustainable Development Goals to eliminate the disease, […] Continue reading -> New Social Contract and One Health Approach Critical to Resilient Recovery from COVID Pandemic 01/10/2021 Madeleine Hoecklin A new social contract between European governments and their citizens is needed to lay the foundation for a resilient and sustainable recovery from the COVID-19 pandemic, with health at the center, said panelists at the closing session of the European Health Forum Gastein (EHFG) on Friday. A focus on ensuring social protection and equitable access […] Continue reading -> MSF Urges Sanofi to Share Technology and Know-how with WHO’s mRNA Vaccine Hub 01/10/2021 Editorial team Following news that Sanofi, a French pharma company, will abandon its promising mRNA COVID-19 vaccine candidate, Médecins Sans Frontières (MSF) called for the corporation to transfer the vaccine technology and know-how to the WHO-led COVID-19 mRNA vaccine technology transfer hub in South Africa. Despite the existence of two approved mRNA vaccines and 13 candidates in advanced stages […] Continue reading -> Childhood Vaccinations Remain High Despite COVID Pandemic 01/10/2021 Editorial team New statistics from Gavi, the Vaccine Alliance show that routine immunisation programmes have been hit hard by the COVID-19 pandemic. However, the latest data shows that there is extraordinary resilience in immunisation systems, with governments’ efforts to keep childhood vaccinations going despite the impact of the pandemic paying dividends. In the face of the pandemic, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> A New Pandemic Treaty, Revised International Health Regulations, or Both? What is the Actual Roadmap? 02/10/2021 Gian Luca Burci The World Health Assembly is set to make a fateful decision in November over whether to negotiate a new international ‘Pandemic Treaty’ to improve future pandemic preparedness and response. However, major players like the United States, backed by some civil society groups, have suggested that revisions of the existing International Health Regulations (IHR) would be […] Continue reading -> Tuberculosis is Here to Stay if We Don’t Mobilise Resources for Diagnoses and Double Fundings, New Data Shows 01/10/2021 Aishwarya Tendolkar The COVID-19 pandemic and the consequent diversion of resources toward battling SARS-CoV2 has also set back global efforts to eliminate the world’s second most deadly infectious killer: Tuberculosis, by 2030. Only a doubling of investments next year can pave the way to attainment of the 2030 United Nations Sustainable Development Goals to eliminate the disease, […] Continue reading -> New Social Contract and One Health Approach Critical to Resilient Recovery from COVID Pandemic 01/10/2021 Madeleine Hoecklin A new social contract between European governments and their citizens is needed to lay the foundation for a resilient and sustainable recovery from the COVID-19 pandemic, with health at the center, said panelists at the closing session of the European Health Forum Gastein (EHFG) on Friday. A focus on ensuring social protection and equitable access […] Continue reading -> MSF Urges Sanofi to Share Technology and Know-how with WHO’s mRNA Vaccine Hub 01/10/2021 Editorial team Following news that Sanofi, a French pharma company, will abandon its promising mRNA COVID-19 vaccine candidate, Médecins Sans Frontières (MSF) called for the corporation to transfer the vaccine technology and know-how to the WHO-led COVID-19 mRNA vaccine technology transfer hub in South Africa. Despite the existence of two approved mRNA vaccines and 13 candidates in advanced stages […] Continue reading -> Childhood Vaccinations Remain High Despite COVID Pandemic 01/10/2021 Editorial team New statistics from Gavi, the Vaccine Alliance show that routine immunisation programmes have been hit hard by the COVID-19 pandemic. However, the latest data shows that there is extraordinary resilience in immunisation systems, with governments’ efforts to keep childhood vaccinations going despite the impact of the pandemic paying dividends. In the face of the pandemic, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
A New Pandemic Treaty, Revised International Health Regulations, or Both? What is the Actual Roadmap? 02/10/2021 Gian Luca Burci The World Health Assembly is set to make a fateful decision in November over whether to negotiate a new international ‘Pandemic Treaty’ to improve future pandemic preparedness and response. However, major players like the United States, backed by some civil society groups, have suggested that revisions of the existing International Health Regulations (IHR) would be […] Continue reading -> Tuberculosis is Here to Stay if We Don’t Mobilise Resources for Diagnoses and Double Fundings, New Data Shows 01/10/2021 Aishwarya Tendolkar The COVID-19 pandemic and the consequent diversion of resources toward battling SARS-CoV2 has also set back global efforts to eliminate the world’s second most deadly infectious killer: Tuberculosis, by 2030. Only a doubling of investments next year can pave the way to attainment of the 2030 United Nations Sustainable Development Goals to eliminate the disease, […] Continue reading -> New Social Contract and One Health Approach Critical to Resilient Recovery from COVID Pandemic 01/10/2021 Madeleine Hoecklin A new social contract between European governments and their citizens is needed to lay the foundation for a resilient and sustainable recovery from the COVID-19 pandemic, with health at the center, said panelists at the closing session of the European Health Forum Gastein (EHFG) on Friday. A focus on ensuring social protection and equitable access […] Continue reading -> MSF Urges Sanofi to Share Technology and Know-how with WHO’s mRNA Vaccine Hub 01/10/2021 Editorial team Following news that Sanofi, a French pharma company, will abandon its promising mRNA COVID-19 vaccine candidate, Médecins Sans Frontières (MSF) called for the corporation to transfer the vaccine technology and know-how to the WHO-led COVID-19 mRNA vaccine technology transfer hub in South Africa. Despite the existence of two approved mRNA vaccines and 13 candidates in advanced stages […] Continue reading -> Childhood Vaccinations Remain High Despite COVID Pandemic 01/10/2021 Editorial team New statistics from Gavi, the Vaccine Alliance show that routine immunisation programmes have been hit hard by the COVID-19 pandemic. However, the latest data shows that there is extraordinary resilience in immunisation systems, with governments’ efforts to keep childhood vaccinations going despite the impact of the pandemic paying dividends. In the face of the pandemic, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Tuberculosis is Here to Stay if We Don’t Mobilise Resources for Diagnoses and Double Fundings, New Data Shows 01/10/2021 Aishwarya Tendolkar The COVID-19 pandemic and the consequent diversion of resources toward battling SARS-CoV2 has also set back global efforts to eliminate the world’s second most deadly infectious killer: Tuberculosis, by 2030. Only a doubling of investments next year can pave the way to attainment of the 2030 United Nations Sustainable Development Goals to eliminate the disease, […] Continue reading -> New Social Contract and One Health Approach Critical to Resilient Recovery from COVID Pandemic 01/10/2021 Madeleine Hoecklin A new social contract between European governments and their citizens is needed to lay the foundation for a resilient and sustainable recovery from the COVID-19 pandemic, with health at the center, said panelists at the closing session of the European Health Forum Gastein (EHFG) on Friday. A focus on ensuring social protection and equitable access […] Continue reading -> MSF Urges Sanofi to Share Technology and Know-how with WHO’s mRNA Vaccine Hub 01/10/2021 Editorial team Following news that Sanofi, a French pharma company, will abandon its promising mRNA COVID-19 vaccine candidate, Médecins Sans Frontières (MSF) called for the corporation to transfer the vaccine technology and know-how to the WHO-led COVID-19 mRNA vaccine technology transfer hub in South Africa. Despite the existence of two approved mRNA vaccines and 13 candidates in advanced stages […] Continue reading -> Childhood Vaccinations Remain High Despite COVID Pandemic 01/10/2021 Editorial team New statistics from Gavi, the Vaccine Alliance show that routine immunisation programmes have been hit hard by the COVID-19 pandemic. However, the latest data shows that there is extraordinary resilience in immunisation systems, with governments’ efforts to keep childhood vaccinations going despite the impact of the pandemic paying dividends. In the face of the pandemic, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
New Social Contract and One Health Approach Critical to Resilient Recovery from COVID Pandemic 01/10/2021 Madeleine Hoecklin A new social contract between European governments and their citizens is needed to lay the foundation for a resilient and sustainable recovery from the COVID-19 pandemic, with health at the center, said panelists at the closing session of the European Health Forum Gastein (EHFG) on Friday. A focus on ensuring social protection and equitable access […] Continue reading -> MSF Urges Sanofi to Share Technology and Know-how with WHO’s mRNA Vaccine Hub 01/10/2021 Editorial team Following news that Sanofi, a French pharma company, will abandon its promising mRNA COVID-19 vaccine candidate, Médecins Sans Frontières (MSF) called for the corporation to transfer the vaccine technology and know-how to the WHO-led COVID-19 mRNA vaccine technology transfer hub in South Africa. Despite the existence of two approved mRNA vaccines and 13 candidates in advanced stages […] Continue reading -> Childhood Vaccinations Remain High Despite COVID Pandemic 01/10/2021 Editorial team New statistics from Gavi, the Vaccine Alliance show that routine immunisation programmes have been hit hard by the COVID-19 pandemic. However, the latest data shows that there is extraordinary resilience in immunisation systems, with governments’ efforts to keep childhood vaccinations going despite the impact of the pandemic paying dividends. In the face of the pandemic, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
MSF Urges Sanofi to Share Technology and Know-how with WHO’s mRNA Vaccine Hub 01/10/2021 Editorial team Following news that Sanofi, a French pharma company, will abandon its promising mRNA COVID-19 vaccine candidate, Médecins Sans Frontières (MSF) called for the corporation to transfer the vaccine technology and know-how to the WHO-led COVID-19 mRNA vaccine technology transfer hub in South Africa. Despite the existence of two approved mRNA vaccines and 13 candidates in advanced stages […] Continue reading -> Childhood Vaccinations Remain High Despite COVID Pandemic 01/10/2021 Editorial team New statistics from Gavi, the Vaccine Alliance show that routine immunisation programmes have been hit hard by the COVID-19 pandemic. However, the latest data shows that there is extraordinary resilience in immunisation systems, with governments’ efforts to keep childhood vaccinations going despite the impact of the pandemic paying dividends. In the face of the pandemic, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Childhood Vaccinations Remain High Despite COVID Pandemic 01/10/2021 Editorial team New statistics from Gavi, the Vaccine Alliance show that routine immunisation programmes have been hit hard by the COVID-19 pandemic. However, the latest data shows that there is extraordinary resilience in immunisation systems, with governments’ efforts to keep childhood vaccinations going despite the impact of the pandemic paying dividends. In the face of the pandemic, […] Continue reading -> Posts navigation Older postsNewer posts